Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
At 1.0 mg total blend per day, each vial covers about 20 daily draws
Science does not always follow a straight line from question to answer
Higher-strength blends often become easier for beginners to measure with 2 mL because the per-unit concentration is less compressed
This reflects several practical and risk-management considerations: Feasibility: 10 mg represents a testable dose that fits typical tablet manufacturing and is easy to dose consistently Precaution: It is substantially lower than the upper range of animal studies when adjusted for expected human bioavailability Tolerability: Community reports suggest 10 mg daily is generally well-tolerated in most users without major adverse effects Observability: At lower doses, any effects (beneficial or adverse) are more likely to be attributable to Dihexa rather than confounding factors Cost-effectiveness: 10 mg balances efficacy expectations with pricing practicality However, "conservative" and "well-tolerated at low doses" does not mean "safe." The absence of clinical trial data means individual responses are unpredictable
Third Party Tested Each batch of GHK-CU is independently analysed by a third party laboratory to confirm identity and purity prior to release
Exercise and metabolic research models in fibromyalgia: beneficial roles of IGF-1 and [PMID: 23446104] Laboratory literature summary: Exercise and metabolic research models in fibromyalgia: beneficial roles of IGF-1 and resistin
